Journal article

Advanced glycation end products present in the obese uterine environment compromise preimplantation embryo development

Jennifer C Hutchison, Thi T Truong, Lois A Salamonsen, David K Gardner, Jemma Evans

REPRODUCTIVE BIOMEDICINE ONLINE | ELSEVIER SCI LTD | Published : 2020

Abstract

Research question Proinflammatory advanced glycation end products (AGE), highly elevated within the uterine cavity of obese women, compromise endometrial function. Do AGE also impact preimplantation embryo development and function? Design Mouse embryos were cultured in AGE equimolar to uterine fluid concentrations in lean (1–2 µmol/l) or obese (4–8 µmol/l) women. Differential nuclear staining identified cell allocation to inner cell mass (ICM) and trophectoderm (TE) (day 4 and 5 of culture). Cell apoptosis was examined by terminal deoxynucleotidyl transferase-mediated dUDP nick-end labelling assay (day 5). Day 4 embryos were placed on bovine serum albumin/fibronectin-coated plates and embryo..

View full abstract

University of Melbourne Researchers

Grants

Funding Acknowledgements

The authors acknowledge Ms Kathryn Gurner for her technical assistance, and Professor Melinda Coughlan for quantification of AGE-HSA. This work was supported in part by: a bridge grant from the Study for Reproductive Investigation (to JE); the Victorian Government Operational Infrastructure support program to the Hudson Institute; University of Melbourne (to TTT and DKG); Australian Government Research Training Program (RTP) Scholarship (to JH); Fielding Foundation fellowship (to JE).